Menu
中文Book a checkup
Cheng Hsin General Hospital Health Management Center · Taipei · Regional hospital

Comprehensive Lab Testing Package G

US$374
NT$12,000 · you pay the hospital in NT$

Without a Taiwan ID or NHI card: about US$449 (NT$14,400), 20% more by the hospital's own rules.

Book this checkup

Prefer to book it yourself? Call Cheng Hsin General Hospital on 02-28264400 ext. 3999 or use its English site ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

A specialty-tier program with Creatine kinase, NT-proBNP and High-sensitivity troponin and a 52-test panel.

English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Creatine kinase

Muscle and heart muscle damage.

NT-proBNP

Heart failure and heart strain.

High-sensitivity troponin

Heart muscle injury.

Every test, in English

52 tests listed, 41 of them on our shared test list, so they line up against other hospitals' packages.

Blood Count3
Liver Function7
Kidney & Electrolytes5
Lipids & Cardiometabolic7
Glucose2
Thyroid & Endocrine3
Tumor Markers7
Infection Serology3
Cardiac3
Allergy1
Show all 52 tests and what each screens for
TestScreens forAdd-on?
Blood Count
Iron studiesIron deficiency or iron overload.Add-on
Rheumatoid factor (RF)A marker associated with rheumatoid arthritis.Incl.
Vitamin B12 and folateDeficiencies that cause anemia and nerve problems.Incl.
Liver Function
AlbuminLiver function and nutrition status.Incl.
Alkaline phosphataseLiver, bile duct and bone conditions.Incl.
Direct bilirubinBile duct obstruction.Incl.
Gamma-GTBile duct and alcohol-related liver stress.Incl.
Globulin and A/G ratioImmune protein levels.Incl.
Total bilirubinJaundice, liver and bile problems.Incl.
Total proteinNutrition and liver/kidney protein handling.Incl.
Kidney & Electrolytes
Blood urea nitrogenKidney function.Incl.
CalciumBone, parathyroid and kidney conditions.Incl.
CreatinineKidney function.Incl.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.Incl.
Uric acidGout risk and kidney stone risk.Incl.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.Incl.
HomocysteineCardiovascular risk marker.Incl.
High-sensitivity CRPInflammation linked to heart disease risk.Incl.
LDL cholesterolThe main cholesterol driving heart disease risk.Incl.
Lipoprotein(a)Inherited cardiovascular risk not captured by LDL.Incl.
Total cholesterolCardiovascular risk.Incl.
TriglyceridesCardiovascular and pancreatitis risk.Incl.
Glucose
Fasting glucoseDiabetes and prediabetes.Incl.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.Incl.
Thyroid & Endocrine
Free T4Thyroid hormone level.Incl.
TSHThyroid function; the primary thyroid screening test.Incl.
Vitamin D (25-OH)Vitamin D deficiency; bone health.Incl.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).Incl.
CA-125Ovarian cancer marker.Incl.
CA 19-9Pancreatic and biliary cancer marker.Incl.
CEAColorectal and other GI cancer marker.Incl.
CYFRA 21-1Lung cancer marker.Incl.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).Incl.
PSAProstate cancer marker.Incl.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).Incl.
Hepatitis C antibodyHepatitis C infection.Incl.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.Incl.
Cardiac
Creatine kinaseMuscle and heart muscle damage.Incl.
NT-proBNPHeart failure and heart strain.Incl.
High-sensitivity troponinHeart muscle injury.Incl.
Allergy
Allergen-specific IgE panelAllergies to common foods and inhalants.Incl.
Blood Count
Iron studiesAdd-on
Iron deficiency or iron overload.
Rheumatoid factor (RF)Incl.
A marker associated with rheumatoid arthritis.
Vitamin B12 and folateIncl.
Deficiencies that cause anemia and nerve problems.
Liver Function
AlbuminIncl.
Liver function and nutrition status.
Alkaline phosphataseIncl.
Liver, bile duct and bone conditions.
Direct bilirubinIncl.
Bile duct obstruction.
Gamma-GTIncl.
Bile duct and alcohol-related liver stress.
Globulin and A/G ratioIncl.
Immune protein levels.
Total bilirubinIncl.
Jaundice, liver and bile problems.
Total proteinIncl.
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenIncl.
Kidney function.
CalciumIncl.
Bone, parathyroid and kidney conditions.
CreatinineIncl.
Kidney function.
Electrolytes (Na, K, Cl)Incl.
Salt and fluid balance; kidney and hormone problems.
Uric acidIncl.
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolIncl.
Protective cholesterol level.
HomocysteineIncl.
Cardiovascular risk marker.
High-sensitivity CRPIncl.
Inflammation linked to heart disease risk.
LDL cholesterolIncl.
The main cholesterol driving heart disease risk.
Lipoprotein(a)Incl.
Inherited cardiovascular risk not captured by LDL.
Total cholesterolIncl.
Cardiovascular risk.
TriglyceridesIncl.
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucoseIncl.
Diabetes and prediabetes.
Hemoglobin A1cIncl.
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4Incl.
Thyroid hormone level.
TSHIncl.
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Incl.
Vitamin D deficiency; bone health.
Tumor Markers
AFPIncl.
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Incl.
Ovarian cancer marker.
CA 19-9Incl.
Pancreatic and biliary cancer marker.
CEAIncl.
Colorectal and other GI cancer marker.
CYFRA 21-1Incl.
Lung cancer marker.
EBV VCA-IgAIncl.
Nasopharyngeal cancer risk (common in Taiwan and southern China).
PSAIncl.
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibodyIncl.
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyIncl.
Hepatitis C infection.
Hepatitis B surface antigenIncl.
Current hepatitis B infection; very common in Taiwan.
Cardiac
Creatine kinaseIncl.
Muscle and heart muscle damage.
NT-proBNPIncl.
Heart failure and heart strain.
High-sensitivity troponinIncl.
Heart muscle injury.
Allergy
Allergen-specific IgE panelIncl.
Allergies to common foods and inhalants.
Also listed: ALT (SGPT), AST (SGOT), Complete blood count (CBC), D-dimer, Family medicine consultation, Fecal immunochemical test (FIT), LDL/HDL ratio, Total cholesterol/HDL ratio, Urinalysis with microscopic sediment exam, White blood cell differential, Zinc.

Before you book

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Cheng Hsin General Hospital Health Management Center
Regional hospital
Taipei · Beitou

About 10 minutes' walk (775 m) from Shipai station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

17 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

  • Payment for the checkup can be made by credit card or cash.

    Source ↗ · checked 2026-09-20

  • Visitors without an ROC ID card or NHI card are charged 1.2 times the local price under the hospital's international medical rules.

    Source ↗ · checked 2026-09-22

Results

  • Specialist physicians give patients an initial explanation of their checkup report on the same day.

    Source ↗ · checked 2026-09-20

  • Based on the patient's medical needs, the center can help refer them to the appropriate outpatient department when the report is explained.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$1,520–1,733 for a woman (37 of 39 tests) and US$1,538–1,761 for a man (37 of 39 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 13 of these tests
Hepatitis C antibody
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
CA 19-9
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Free T4
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hepatitis B surface antigen
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
HDL cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
High-sensitivity CRP
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
PSA
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Vitamin D (25-OH)
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 3 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Comprehensive Lab Testing Package G
US$374
Book this checkup

If this isn't quite right

Same hospital, adds Breast ultrasound
Basic General Checkup Package
Cheng Hsin General Hospital Health Management Center
US$467
Same focus, Tainan
Refined Plan
Chi Mei Hospital Liouying Health Management Center
US$374

Other packages at Cheng Hsin General Hospital

PackageTestsPrice
Basic General Checkup Package62
US$467
NT$15,000
Women US$530
+20% without Taiwan ID or NHI card
Entry-Level Cardiac Checkup Package48
US$467
NT$15,000
+20% without Taiwan ID or NHI card
Ultimate Lab Testing Package H65
US$498
NT$16,000
+20% without Taiwan ID or NHI card
Advanced Cardiac Checkup Package51
US$623
NT$20,000
+20% without Taiwan ID or NHI card
Standard General Checkup Package71
US$623
NT$20,000
Women US$685
+20% without Taiwan ID or NHI card
Elite General Checkup Package84
US$935
NT$30,000
Women US$997
+20% without Taiwan ID or NHI card
Senior Cardiac Checkup Package52
US$1,433
NT$46,000
+20% without Taiwan ID or NHI card
Enhanced Whole-Body MRI Cancer-Screening Checkup Package29
US$1,620
NT$52,000
Women from US$1,682
+20% without Taiwan ID or NHI card
Comprehensive Whole-Body MRI Cancer-Screening Checkup Package78
US$2,056
NT$66,000
Women from US$2,118
+20% without Taiwan ID or NHI card
Top-Tier Cardio-Cerebrovascular Checkup Package62
US$2,056
NT$66,000
+20% without Taiwan ID or NHI card

All packages at Cheng Hsin General Hospital Health Management Center →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
Liver Care Health CheckupPojen General Hospital51
US$312
NT$10,000
Cardiovascular Disease ScreeningTaiwan Adventist Hospital Health Management Center27
US$312
NT$10,000
Cardiovascular Care Health CheckupPojen General Hospital45
US$280
NT$9,000
Cerebrovascular Care Health CheckupPojen General Hospital42
US$280
NT$9,000

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · All checkups in Taipei · What a checkup costs in Taiwan